Long-Term Persistence and Recovery of Short-Term Memory Loss in COVID-19 Survivors: A 3.5-Year Follow-Up Study
Jha, R. K.; Narayan, R. K.; Paikra, S. K.; Ghosh, S. K.; Kirti, R.; Rai, D. K.; Banerjee, A.; Sarfaraz, A.; Kumar, A.
Show abstract
BackgroundShort-term memory loss is a common persistent symptom reported in recovered COVID-19 patients. This study evaluated its long-term persistence in a cohort of hospitalized COVID-19 patients following discharge. Materials and MethodsA total of 207 hospitalized COVID-19 patients were followed up for three and a half years after discharge. They were interviewed via telephone and asked about symptoms indicative of short-term memory loss, such as increased forgetfulness or difficulty retaining recent information. A memory loss score was then created based on their responses. A time-based recovery trend was plotted, which served as the basis for modeling the further course of the illness. Additionally, a retrospective analysis of hospital records, including clinical, laboratory, and treatment data for each patient, was conducted. The test data were statistically compared with an age, sex, and comorbidity-matched cohort that did not exhibit significant long COVID symptoms. ResultsShort-term memory loss was observed in approximately 11.5% (24/207) of patients. After three and a half years, 25% (6/24) had fully recovered (faster recovery group), 37.5% (9/24) showed improvement (gradual recovery group), and 29% (7/24) exhibited little to no progress (slow recovery group). Two patients with memory loss passed away during the study. Time trend analysis revealed significant symptom recovery over the study period (p < 0.001). Model predictions based on trend data estimate the maximum recovery period for the gradual recovery group to be 3.7 years. However, symptoms in the slow recovery group may persist for up to 14 years. Higher age and comorbidities were the strongest predictors of recovery speed. In contrast, patient sex, blood group, hospital stay duration, illness severity, and levels of inflammatory, metabolic, and thrombosis markers during hospitalization showed no significant impact (p > 0.05) compared to the COVID-19 survivors with no memory loss or other long COVID symptoms. ConclusionSignificant recovery from memory loss can occur over time in COVID-19 survivors; however, symptoms persist in most patients even three and a half years after hospital discharge. A longer follow-up period may be necessary to assess the long-term trajectory of long COVID patients.
Matching journals
The top 11 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Correlates of patient-reported cognitive performance with regard to disability 93%
- More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis 93%
- Patients Recovering from COVID-19 who Presented Anosmia During their Acute Episode have Behavioral, Functional, and Structural Brain Alterations 92%
Similar papers in this journal
- The negative impact of COVID-19 on working memory revealed using a rapid online quiz 94%
- Self-reported health, neuropsychological tests and biomarkers in fully recovered COVID-19 patients vs patients with post-COVID cognitive symptoms: a pilot study 94%
- The Healthy Brain 9 (HB9): A New Instrument to Characterize Subjective Cognitive Decline, and Detect Anosognosia in Mild Cognitive Impairment 92%
Similar papers in this journal
- Comparing COVID-19 and influenza presentation and trajectory 91%
- SARS-CoV-2 viremia precedes an IL6 response in severe COVID-19 patients: results of a longitudinal prospective cohort 90%
- Clinical findings in critical ill patients infected with SARS-Cov-2 in Guangdong Province, China: a multi-center, retrospective, observational study 89%
Similar papers in this journal
- A Prospective Study of Long-Term Outcomes Among Hospitalized COVID-19 Patients with and without Neurological Complications 94%
- Cerebrospinal fluid in COVID-19 neurological complications: no cytokine storm or neuroinflammation 92%
- A machine learning-based holistic approach for the diagnosis of patients suffering from different conditions within the Alzheimer’s disease spectrum 90%
Similar papers in this journal
- Cortical thickness alterations and systemic inflammation define long-COVID patients with cognitive impairment 93%
- Serum Neurofilament Light Chain Increases in Healthy Postpartum: Is It Subclinical Brain Damage or Neuroplasticity? 92%
- Immune activation and immune-associated neurotoxicity in Long-COVID: A systematic review and meta-analysis of 82 studies comprising 58 cytokines/chemokines/growth factors. 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.